cdmo.directory
← Compare landing

PolyPeptide Group vs Sinopep-Allsino Biopharmaceutical Co., Ltd.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/polypeptide/sinopep

CategoryPolyPeptide GroupSinopep-Allsino Biopharmaceutical Co., Ltd.
Listed sitecdmocdmo
SummarySpecialized global CDMO for peptide-based active pharmaceutical ingredients, supporting development and manufacturing of proprietary and generic APIs with expertise in peptide synthesis and GMP manufacturing.GMP peptide and oligonucleotide CDMO offering custom synthesis, NCE development, CMC manufacturing, and finished dosage form formulation services for therapeutic programs.
Services
  • Peptide Manufacturing
  • Process Development
  • Quality Control Testing
  • Technology Transfer
  • CMC Regulatory Submission Support
  • CMC Analytical Development
  • API Synthesis & Manufacturing
  • Peptide Manufacturing
  • Oligonucleotide Manufacturing
  • Formulation Development
  • Process Development
  • CMC Analytical Development
  • CMC Regulatory Submission Support
Modalities
  • Peptide
  • Peptide
  • Oligonucleotide
Indications
  • Metabolic
Data not yet provided.
Locations
  • Headquarters, Baar, Switzerland
Data not yet provided.
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.